The DOI matches its Crossref record; 219 of the 219 references it cites were found in a registry or an index.
Polyethylene Glycol Immunogenicity: Theoretical, Clinical, and Practical Aspects of Anti-Polyethylene Glycol Antibodies
Open accessAbstract
Polyethylene glycol (PEG) is a flexible, hydrophilic simple polymer that is physically attached to peptides, proteins, nucleic acids, liposomes, and nanoparticles to reduce renal clearance, block antibody and protein binding sites, and enhance the half-life and efficacy of therapeutic molecules. Some naïve individuals have pre-existing antibodies that can bind to PEG, and some PEG-modified compounds induce additional antibodies against PEG, which can adversely impact drug efficacy and safety. Here we provide a framework to better understand PEG immunogenicity and how antibodies against PEG affect pegylated drug and nanoparticles. Analysis of published studies reveals rules for predicting accelerated blood clearance of pegylated medicine and therapeutic liposomes. Experimental studies of anti-PEG antibody binding to different forms, sizes, and immobilization states of PEG are also provided. The widespread use of SARS-CoV-2 RNA vaccines that incorporate PEG in lipid nanoparticles make understanding possible effects of anti-PEG antibodies on pegylated medicines even more critical.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–219 of 219
Selective Delivery of PEGylated Compounds to Tumor Cells by Anti-PEG Hybrid Antibodies
Tung, H.-Y., Su, Y.-C., Chen, B., Burnouf, P., Huang, W.-C., Chuang, K.-H., Yan, Y.-T., Cheng, T., & Roffler, S. R. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-0151 · Cited by 34
Self-citationMyler, H. A., Hruska, M. W., Srinivasan, S., Cooney, E. L., Kong, G., Dodge, R. W., Krishna, M., Zhu, J., Felix, T., Gleason, C. R., et al. (2015) · Bioanalysis · doi:10.4155/bio.15.36 · Cited by 34
Ho, K., Chen, I.-H., Cheng, Y., Liao, T.-Y., Liu, E.-S., Chen, H.-J., Lu, Y.-C., Su, Y.-C., Roffler, S. R., Huang, B., et al. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-020-00752-w · Cited by 32
Self-citationUrticarial reaction to oral polyethylene glycol electrolyte lavage solution
Brullet, E., Morón, A., Calvet, X., Frias, C., & Sola, J. (1992) · Gastrointestinal Endoscopy · doi:10.1016/s0016-5107(92)70454-4 · Cited by 30
Lila, A. S. A., Ichihara, M., Shimizu, T., Ishida, T., & Kiwada, H. (2013) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b13-00562 · Cited by 29
Chang, T.-C., Chen, B., Lin, W.-W., Yu, P., Chiu, Y., Chen, Y.-T., Wu, J., Cheng, T., Hwang, D., & Roffler, S. R. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics12010015 · Cited by 29
Self-citationElsadek, N. E., Hondo, E., Shimizu, T., Takata, H., Lila, A. S. A., Emam, S. E., Ando, H., Ishima, Y., & Ishida, T. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00366 · Cited by 29
Reloadable multidrug capturing delivery system for targeted ischemic disease treatment
Wu, J. P. J., Cheng, B., Roffler, S. R., Lundy, D. J., Yen, C. Y. T., Chen, P., Lai, J. J., Pun, S. H., Stayton, P. S., & Hsieh, P. C. H. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aah6228 · Cited by 27
Self-citationCross-Reactivity of Select PEG-Binding Antibodies to Other Polymers Containing a C-C-O Backbone
McCallen, J., Prybylski, J. P., Yang, Q., & Lai, S. K. (2017) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.7b00147 · Cited by 27
Tardi, P. G., Swartz, E. N., Harasym, T. O., Cullis, P. R., & Bally, M. B. (1997) · Journal of Immunological Methods · doi:10.1016/s0022-1759(97)00178-6 · Cited by 26
Chen, I., Cheng, Y., Ho, K., Lin, W.-W., Cheng, K.-W., Lu, Y., Hsieh, Y.-C., Huang, C.-C., Chuang, C.-H., Chen, F., et al. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.04.029 · Cited by 26
Self-citationChang, T.-C., Chen, B., Wu, J.-Y., Cheng, T., & Roffler, S. R. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112502 · Cited by 26
Self-citationActivation of TLR9 by incorporated pDNA within PEG-coated lipoplex enhances anti-PEG IgM production
Hashimoto, Y., Uehara, Y., Lila, A. S. A., Ishida, T., & Kiwada, H. (2014) · Gene Therapy · doi:10.1038/gt.2014.32 · Cited by 23
Anaphylactic Shock Caused by Ingestion of Polyethylene Glycol
Lee, S. H., Cha, J. M., Lee, J. I., Joo, K. R., Shin, H. P., Baek, I. H., Jeon, J. W., Lim, J. U., Lee, J. L., Lee, H. M., et al. (2015) · Intestinal Research · doi:10.5217/ir.2015.13.1.90 · Cited by 23
Browne, E. K., Moore, C., Sykes, A. D., Lu, Z., Jeha, S., & Mandrell, B. N. (2017) · Journal of Pediatric Oncology Nursing · doi:10.1177/1043454217741868 · Cited by 23
Lin, W.-W., Hsieh, Y.-C., Cheng, Y., Chuang, K., Huang, C.-C., Chuang, C.-H., Chen, I., Cheng, K.-W., Lu, Y., Cheng, T.-C., et al. (2016) · Analytical Chemistry · doi:10.1021/acs.analchem.6b03614 · Cited by 22
Self-citationAndlauer, T. F. M., Link, J., Martin, D., Ryner, M. L., Hermanrud, C. E., Grummel, V., Auer, M., Hegen, H., Aly, L., Gasperi, C., et al. (2020) · BMC Medicine · doi:10.1186/s12916-020-01769-6 · Cited by 18
Oja, C. D., Tardi, P. G., Schutze-Redelmeier, M.-P. M., & Cullis, P. R. (2000) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(00)00178-4 · Cited by 12
Chuang, H.-Y., Suen, C., Hwang, M., & Roffler, S. R. (2015) · Protein Engineering Design and Selection · doi:10.1093/protein/gzv041 · Cited by 12
Self-citation
Cited by
Anti-PEG Antibodies Boosted in Humans by SARS-CoV-2 Lipid Nanoparticle mRNA Vaccine
Ju, Y., Lee, W. S., Pilkington, E. H., Kelly, H. G., Li, S., Selva, K. J., Wragg, K. M., Subbarao, K., Nguyen, T. H. O., Rowntree, L. C., et al. (2022) · ACS Nano · doi:10.1021/acsnano.2c04543 · Cited by 372
PEGylated Lipid Nanoparticle Formulations: Immunological Safety and Efficiency Perspective
Tenchov, R., Sasso, J. M., & Zhou, Q. A. (2023) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.3c00174 · Cited by 313
Lipid nanoparticles for delivery of RNA therapeutics: Current status and the role of in vivo imaging
Jung, H. N., Lee, S.-Y., Lee, S., Youn, H., & Im, H.-J. (2022) · Theranostics · doi:10.7150/thno.77259 · Cited by 282
Impact of anti-PEG antibodies induced by SARS-CoV-2 mRNA vaccines
Ju, Y., Carreño, J. M., Simon, V., Dawson, K., Krammer, F., & Kent, S. J. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-022-00825-x · Cited by 201
The Dawn of a New Era: Targeting the “Undruggables” with Antibody-Based Therapeutics
Qian, L., Lin, X., Gao, X., Khan, R. U., Liao, J.-Y., Du, S., Ge, J., Zeng, S., & Yao, S. Q. (2023) · Chemical Reviews · doi:10.1021/acs.chemrev.2c00915 · Cited by 155
Metadata
- Authors
- Chen, B.-M., Cheng, T.-L., & Roffler, S. R.
- Venue
- ACS Nano
- Publisher
- American Chemical Society (ACS)
- Published
- 2021-09-01
- Volume
- 15
- Issue
- 9
- Pages
- 14022-14048
- ISSN
- 1936-0851 (ISSN-L)
- 1936-086X
- OpenAlex
- W3198884354
- Cited by
- 563
- References
- 219
- FWCI
- 15.54
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.